Navigating Breast Cancer: Axon Guidance Molecules as Breast Cancer Tumor Suppressors and Oncogenes
Authors:
- 5 August 2011
- journal article
- review article
- Published by Springer Nature in Journal of Mammary Gland Biology and Neoplasia
- Vol. 16 (3) , 257-270
Abstract
Slit, Netrin, Ephrin, and Semaphorin’s roles in development have expanded greatly in the past decade from their original characterization as axon guidance molecules (AGMs) to include roles as regulators of tissue morphogenesis and development in diverse organs. In the mammary gland, AGMs are important for maintaining normal cell proliferation and adhesion during development. The frequent dysregulation of AGM expression during tumorigenesis and tumor progression suggests that AGMs also play a crucial role as tumor suppressors and oncogenes in breast cancer. Moreover, these findings suggest that AGMs may be excellent targets for new breast cancer prognostic tests and more effective therapeutic strategies.Keywords
This publication has 91 references indexed in Scilit:
- SLIT/ROBO1 Signaling Suppresses Mammary Branching Morphogenesis by Limiting Basal Cell NumberDevelopmental Cell, 2011
- Novel roles for Slits and netrins: axon guidance cues as anticancer targets?Nature Reviews Cancer, 2011
- Eph receptors and ephrins in cancer: bidirectional signalling and beyondNature Reviews Cancer, 2010
- Interfering with multimerization of netrin-1 receptors triggers tumor cell deathCell Death & Differentiation, 2009
- Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptorOncogene, 2008
- Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cellsBreast Cancer Research and Treatment, 2008
- EphrinB1 controls cell–cell junctions through the Par polarity complexNature Cell Biology, 2008
- Candidate regulators of mammary branching morphogenesis identified by genome‐wide transcript analysisDevelopmental Dynamics, 2006
- The neuronal repellent Slit inhibits leukocyte chemotaxis induced by chemotactic factorsNature, 2001
- The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularizationOncogene, 2000